Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


Oliena Studio

Stroke and language recovery: 9000+ videos

EspañolItalianoSarduEnglish | PDF+


  Chronic Renal Failure

  Free Subscription


Articles published in PLoS One

Retrieve available abstracts of 171 articles:
HTML format
Text format



Single Articles


    January 2019
  1. MATSUMOTO Y, Mori Y, Kageyama S, Arihara K, et al
    Changes in QTc interval in long-term hemodialysis patients.
    PLoS One. 2019;14:e0209297.
    PubMed     Text format     Abstract available


  2. NISHIWAKI H, Hasegawa T, Koiwa F, Hamano T, et al
    The association of the difference in hemoglobin levels before and after hemodialysis with the risk of 1-year mortality in patients undergoing hemodialysis. Results from a nationwide cohort study of the Japanese Renal Data Registry.
    PLoS One. 2019;14:e0210533.
    PubMed     Text format     Abstract available


  3. SHAH S, Meganathan K, Christianson AL, Leonard AC, et al
    Pre-dialysis acute care hospitalizations and clinical outcomes in dialysis patients.
    PLoS One. 2019;14:e0209578.
    PubMed     Text format     Abstract available


  4. MURALI KM, Mullan J, Roodenrys S, Hassan HC, et al
    Strategies to improve dietary, fluid, dialysis or medication adherence in patients with end stage kidney disease on dialysis: A systematic review and meta-analysis of randomized intervention trials.
    PLoS One. 2019;14:e0211479.
    PubMed     Text format     Abstract available


  5. JEONG S, Kwon H, Chang JW, Kim MJ, et al
    Patency rates of arteriovenous fistulas created before versus after hemodialysis initiation.
    PLoS One. 2019;14:e0211296.
    PubMed     Text format     Abstract available


  6. GARNIER F, Couchoud C, Landais P, Moranne O, et al
    Increased incidence of acute kidney injury requiring dialysis in metropolitan France.
    PLoS One. 2019;14:e0211541.
    PubMed     Text format     Abstract available


  7. STEYAERT S, Holvoet E, Nagler E, Malfait S, et al
    Reporting of "dialysis adequacy" as an outcome in randomised trials conducted in adults on haemodialysis.
    PLoS One. 2019;14:e0207045.
    PubMed     Text format     Abstract available


  8. YAJIMA T, Arao M, Yajima K, Takahashi H, et al
    The associations of fat tissue and muscle mass indices with all-cause mortality in patients undergoing hemodialysis.
    PLoS One. 2019;14:e0211988.
    PubMed     Text format     Abstract available


  9. PEDRINI LA, Zawada AM, Winter AC, Pham J, et al
    Effects of high-volume online mixed-hemodiafiltration on anemia management in dialysis patients.
    PLoS One. 2019;14:e0212795.
    PubMed     Text format     Abstract available


  10. GACKLER A, Rohn H, Lisman T, Benko T, et al
    Evaluation of hemostasis in patients with end-stage renal disease.
    PLoS One. 2019;14:e0212237.
    PubMed     Text format     Abstract available


  11. TAKADA D, Kunisawa S, Fushimi K, Imanaka Y, et al
    Previously-initiated hemodialysis as prognostic factor for in-hospital mortality in pneumonia patients with stage 5 chronic kidney disease: Retrospective database study of Japanese hospitals.
    PLoS One. 2019;14:e0213105.
    PubMed     Text format     Abstract available


  12. BLOCK GA, Chertow GM, Sullivan JT, Deng H, et al
    An integrated analysis of safety and tolerability of etelcalcetide in patients receiving hemodialysis with secondary hyperparathyroidism.
    PLoS One. 2019;14:e0213774.
    PubMed     Text format     Abstract available


  13. CHEN SW, Lu YA, Lee CC, Chou AH, et al
    Long-term outcomes after extracorporeal membrane oxygenation in patients with dialysis-requiring acute kidney injury: A cohort study.
    PLoS One. 2019;14:e0212352.
    PubMed     Text format     Abstract available


  14. KOSNIK MB, Reif DM, Lobdell DT, Astell-Burt T, et al
    Associations between access to healthcare, environmental quality, and end-stage renal disease survival time: Proportional-hazards models of over 1,000,000 people over 14 years.
    PLoS One. 2019;14:e0214094.
    PubMed     Text format     Abstract available


  15. TSUJIKAWA H, Tanaka S, Matsukuma Y, Kanai H, et al
    Development of a risk prediction model for infection-related mortality in patients undergoing peritoneal dialysis.
    PLoS One. 2019;14:e0213922.
    PubMed     Text format     Abstract available


  16. KANDA E, Kato A, Masakane I, Kanno Y, et al
    A new nutritional risk index for predicting mortality in hemodialysis patients: Nationwide cohort study.
    PLoS One. 2019;14:e0214524.
    PubMed     Text format     Abstract available


  17. RENDERS L, Budde K, Rosenberger C, van Swelm R, et al
    First-in-human Phase I studies of PRS-080#22, a hepcidin antagonist, in healthy volunteers and patients with chronic kidney disease undergoing hemodialysis.
    PLoS One. 2019;14:e0212023.
    PubMed     Text format     Abstract available


  18. SHUKLA AM, Hinkamp C, Segal E, Ozrazgat Baslanti T, et al
    What do the US advanced kidney disease patients want? Comprehensive pre-ESRD Patient Education (CPE) and choice of dialysis modality.
    PLoS One. 2019;14:e0215091.
    PubMed     Text format     Abstract available


  19. HSU YH, Yen YC, Lin YC, Sung LC, et al
    Correction: Antiplatelet agents maintain arteriovenous fistula and graft function in patients receiving hemodialysis: A nationwide case-control study.
    PLoS One. 2019;14:e0215546.
    PubMed     Text format     Abstract available


  20. WEIDHASE L, Haussig E, Haussig S, Kaiser T, et al
    Middle molecule clearance with high cut-off dialyzer versus high-flux dialyzer using continuous veno-venous hemodialysis with regional citrate anticoagulation: A prospective randomized controlled trial.
    PLoS One. 2019;14:e0215823.
    PubMed     Text format     Abstract available


  21. KIM S, Wu F, Dahlerus C, Chyn D, et al
    Comparative effectiveness analysis of Medicare dialysis facility survey processes.
    PLoS One. 2019;14:e0216038.
    PubMed     Text format     Abstract available


  22. YI SW, Moon SJ, Yi JJ
    Low-normal hemoglobin levels and anemia are associated with increased risk of end-stage renal disease in general populations: A prospective cohort study.
    PLoS One. 2019;14:e0215920.
    PubMed     Text format     Abstract available


  23. CHOI SR, Lee YK, Cho AJ, Park HC, et al
    Malnutrition, inflammation, progression of vascular calcification and survival: Inter-relationships in hemodialysis patients.
    PLoS One. 2019;14:e0216415.
    PubMed     Text format     Abstract available


  24. CHOU MC, Ko CH, Hsieh TJ, Chang JM, et al
    A preliminary report of longitudinal white matter alterations in patients with end-stage renal disease: A three-year diffusion tensor imaging study.
    PLoS One. 2019;14:e0215942.
    PubMed     Text format     Abstract available


  25. PAN KC, Hung SY, Chen CI, Lu CY, et al
    Social support as a mediator between sleep disturbances, depressive symptoms, and health-related quality of life in patients undergoing hemodialysis.
    PLoS One. 2019;14:e0216045.
    PubMed     Text format     Abstract available


  26. WAZIRI B, Musenge E, Duarte R, Dickens C, et al
    Associations of plasma fibroblast growth factor 23 and other markers of chronic kidney disease-Mineral and bone disorder with all-cause mortality in South African patients on maintenance dialysis: A 3-year prospective cohort study.
    PLoS One. 2019;14:e0216656.
    PubMed     Text format     Abstract available


  27. XUE Y, Xu B, Su C, Han Q, et al
    Cardiorenal syndrome in incident peritoneal dialysis patients: What is its effect on patients' outcomes?
    PLoS One. 2019;14:e0218082.
    PubMed     Text format     Abstract available


  28. SUGANO N, Maruyama Y, Kidoguchi S, Ohno I, et al
    Effect of hyperuricemia and treatment for hyperuricemia in Japanese hemodialysis patients: A cohort study.
    PLoS One. 2019;14:e0217859.
    PubMed     Text format     Abstract available


  29. WU PH, Lin MY, Huang TH, Lin YT, et al
    Depression amongst patients commencing maintenance dialysis is associated with increased risk of death and severe infections: A nationwide cohort study.
    PLoS One. 2019;14:e0218335.
    PubMed     Text format     Abstract available


  30. NDLOVU KCZ, Chikobvu P, Mofokeng T, Gounden V, et al
    Serum albumin and mortality in patients with HIV and end-stage renal failure on peritoneal dialysis.
    PLoS One. 2019;14:e0218156.
    PubMed     Text format     Abstract available


    January 2018
  31. KUO CH, Lin YL, Lee CJ, Wang CH, et al
    Hyperleptinemia positively associated with central arterial stiffness in hemodialysis patients.
    PLoS One. 2018;13:e0190694.
    PubMed     Text format     Abstract available


  32. GAYRARD N, Ficheux A, Duranton F, Guzman C, et al
    Correction: Consequences of increasing convection onto patient care and protein removal in hemodialysis.
    PLoS One. 2018;13:e0190761.
    PubMed     Text format     Abstract available


  33. CHERNG YG, Lin CS, Shih CC, Hsu YH, et al
    Stroke risk and outcomes in patients with chronic kidney disease or end-stage renal disease: Two nationwide studies.
    PLoS One. 2018;13:e0191155.
    PubMed     Text format     Abstract available


  34. HARM S, Schildbock C, Hartmann J
    Removal of stabilizers from human serum albumin by adsorbents and dialysis used in blood purification.
    PLoS One. 2018;13:e0191741.
    PubMed     Text format     Abstract available


  35. ALVES FC, Sun J, Qureshi AR, Dai L, et al
    The higher mortality associated with low serum albumin is dependent on systemic inflammation in end-stage kidney disease.
    PLoS One. 2018;13:e0190410.
    PubMed     Text format     Abstract available


  36. ISHIKAWA S, Naito S, Iimori S, Takahashi D, et al
    Loop diuretics are associated with greater risk of sarcopenia in patients with non-dialysis-dependent chronic kidney disease.
    PLoS One. 2018;13:e0192990.
    PubMed     Text format     Abstract available


  37. IIMORI S, Naito S, Noda Y, Sato H, et al
    Prognosis of chronic kidney disease with normal-range proteinuria: The CKD-ROUTE study.
    PLoS One. 2018;13:e0190493.
    PubMed     Text format     Abstract available


  38. WANIEWSKI J, Debowska M, Wojcik-Zaluska A, Ksiazek A, et al
    Correction: Quantification of Dialytic Removal and Extracellular Calcium Mass Balance during a Weekly Cycle of Hemodialysis.
    PLoS One. 2018;13:e0193604.
    PubMed     Text format     Abstract available


  39. ETINGER A, Kumar, Ackley W, Soiefer L, et al
    The effect of isohydric hemodialysis on the binding and removal of uremic retention solutes.
    PLoS One. 2018;13:e0192770.
    PubMed     Text format     Abstract available


  40. FU CF, Huang JD, Wang JT, Lin SW, et al
    The ratio of pre-dialysis vancomycin trough serum concentration to minimum inhibitory concentration is associated with treatment outcomes in methicillin-resistant Staphylococcus aureus bacteremia.
    PLoS One. 2018;13:e0193585.
    PubMed     Text format     Abstract available


  41. JUNG HY, Kim SH, Jang HM, Lee S, et al
    Individualized prediction of mortality using multiple inflammatory markers in patients on dialysis.
    PLoS One. 2018;13:e0193511.
    PubMed     Text format     Abstract available


  42. KOOIMAN J, de Vries JPM, Van der Heyden J, Sijpkens YWJ, et al
    Randomized trial of one-hour sodium bicarbonate vs standard periprocedural saline hydration in chronic kidney disease patients undergoing cardiovascular contrast procedures.
    PLoS One. 2018;13:e0189372.
    PubMed     Text format     Abstract available


  43. AOUN M, Karam R, Sleilaty G, Antoun L, et al
    Iron deficiency across chronic kidney disease stages: Is there a reverse gender pattern?
    PLoS One. 2018;13:e0191541.
    PubMed     Text format     Abstract available


  44. DUONG TV, Wong TC, Chen HH, Chen TW, et al
    The cut-off values of dietary energy intake for determining metabolic syndrome in hemodialysis patients: A clinical cross-sectional study.
    PLoS One. 2018;13:e0193742.
    PubMed     Text format     Abstract available


  45. MAS S, Bosch-Panadero E, Abaigar P, Camarero V, et al
    Influence of dialysis membrane composition on plasma bisphenol A levels during online hemodiafiltration.
    PLoS One. 2018;13:e0193288.
    PubMed     Text format     Abstract available


  46. RAHMAN A, Yamazaki D, Sufiun A, Kitada K, et al
    A novel approach to adenine-induced chronic kidney disease associated anemia in rodents.
    PLoS One. 2018;13:e0192531.
    PubMed     Text format     Abstract available


  47. HAN BG, Song SH, Yoo JS, Park H, et al
    Association between OH/ECW and echocardiographic parameters in CKD5 patients not undergoing dialysis.
    PLoS One. 2018;13:e0195202.
    PubMed     Text format     Abstract available


  48. FUERTINGER DH, Kappel F, Zhang H, Thijssen S, et al
    Prediction of hemoglobin levels in individual hemodialysis patients by means of a mathematical model of erythropoiesis.
    PLoS One. 2018;13:e0195918.
    PubMed     Text format     Abstract available


  49. KOMENDA P, Tangri N, Klajncar E, Eng A, et al
    Patterns of emergency department utilization by patients on chronic dialysis: A population-based study.
    PLoS One. 2018;13:e0195323.
    PubMed     Text format     Abstract available


  50. REGOLISTI G, Maggiore U, Sabatino A, Gandolfini I, et al
    Interaction of healthcare staff's attitude with barriers to physical activity in hemodialysis patients: A quantitative assessment.
    PLoS One. 2018;13:e0196313.
    PubMed     Text format     Abstract available


  51. SETHI SK, Bansal SB, Khare A, Dhaliwal M, et al
    Heparin free dialysis in critically sick children using sustained low efficiency dialysis (SLEDD-f): A new hybrid therapy for dialysis in developing world.
    PLoS One. 2018;13:e0195536.
    PubMed     Text format     Abstract available


  52. PARK JY, Cho JH, Jang HM, Kim YS, et al
    Survival predictors in anuric patients on peritoneal dialysis: A prospective, multicenter, propensity score-matched cohort study.
    PLoS One. 2018;13:e0196294.
    PubMed     Text format     Abstract available


  53. GATWOOD J, Chisholm-Burns M, Davis R, Thomas F, et al
    Evidence of chronic kidney disease in veterans with incident diabetes mellitus.
    PLoS One. 2018;13:e0192712.
    PubMed     Text format     Abstract available


  54. LU W, Kwan BC, Chow KM, Pang WF, et al
    Peritoneal dialysis-related peritonitis caused by Pseudomonas species: Insight from a post-millennial case series.
    PLoS One. 2018;13:e0196499.
    PubMed     Text format     Abstract available


  55. FENTON A, Jesky MD, Webster R, Stringer SJ, et al
    Association between urinary free light chains and progression to end stage renal disease in chronic kidney disease.
    PLoS One. 2018;13:e0197043.
    PubMed     Text format     Abstract available


  56. PARK JM, Lee JH, Jang HM, Park Y, et al
    Survival in patients on hemodialysis: Effect of gender according to body mass index and creatinine.
    PLoS One. 2018;13:e0196550.
    PubMed     Text format     Abstract available


  57. DUPONT V, Kanagaratnam L, Sigogne M, Bechade C, et al
    Outcome of polycystic kidney disease patients on peritoneal dialysis: Systematic review of literature and meta-analysis.
    PLoS One. 2018;13:e0196769.
    PubMed     Text format     Abstract available


  58. LIN MY, Cheng LJ, Chiu YW, Hsieh HM, et al
    Effect of national pre-ESRD care program on expenditures and mortality in incident dialysis patients: A population-based study.
    PLoS One. 2018;13:e0198387.
    PubMed     Text format     Abstract available


  59. NAKANISHI K, Shishido K, Kumata C, Ito K, et al
    Bone density of the femoral neck in patients on maintenance dialysis.
    PLoS One. 2018;13:e0197965.
    PubMed     Text format     Abstract available


  60. KAWAI Y, Masutani K, Torisu K, Katafuchi R, et al
    Association between serum albumin level and incidence of end-stage renal disease in patients with Immunoglobulin A nephropathy: A possible role of albumin as an antioxidant agent.
    PLoS One. 2018;13:e0196655.
    PubMed     Text format     Abstract available


  61. LIN SY, Tu HP, Chen TC, Shen MC, et al
    Association of bacterial genotypes and epidemiological features with treatment failure in hemodialysis patients with methicillin-resistant Staphylococcus aureus bacteremia.
    PLoS One. 2018;13:e0198486.
    PubMed     Text format     Abstract available


  62. GUBENSEK J, Strobl K, Harm S, Weiss R, et al
    Influence of citrate concentration on the activation of blood cells in an in vitro dialysis setup.
    PLoS One. 2018;13:e0199204.
    PubMed     Text format     Abstract available


  63. YONEMOTO S, Hamano T, Fujii N, Shimada K, et al
    Red cell distribution width and renal outcome in patients with non-dialysis-dependent chronic kidney disease.
    PLoS One. 2018;13:e0198825.
    PubMed     Text format     Abstract available


  64. REGOLISTI G, Maggiore U, Sabatino A, Gandolfini I, et al
    Correction: Interaction of healthcare staff's attitude with barriers to physical activity in hemodialysis patients: A quantitative assessment.
    PLoS One. 2018;13:e0198987.
    PubMed     Text format     Abstract available


  65. AGBAS A, Canpolat N, Caliskan S, Yilmaz A, et al
    Hemodiafiltration is associated with reduced inflammation, oxidative stress and improved endothelial risk profile compared to high-flux hemodialysis in children.
    PLoS One. 2018;13:e0198320.
    PubMed     Text format     Abstract available


  66. NICOLETTO BB, Pedrollo EF, Carpes LS, Coloretti NG, et al
    Progranulin serum levels in human kidney transplant recipients: A longitudinal study.
    PLoS One. 2018;13:e0192959.
    PubMed     Text format     Abstract available


  67. BORRAS SANS M, Perez-Fontan M, Martinez-Alonso M, Bajo A, et al
    Correction: The modality of dialysis does not influence atheromatous vascular disease progression or cardiovascular outcomes in dialysis patients without previous cardiovascular disease.
    PLoS One. 2018;13:e0200226.
    PubMed     Text format     Abstract available


  68. MIYAZAWA H, Ookawara S, Ito K, Ueda Y, et al
    Association of cerebral oxygenation with estimated glomerular filtration rate and cognitive function in chronic kidney disease patients without dialysis therapy.
    PLoS One. 2018;13:e0199366.
    PubMed     Text format     Abstract available


  69. OKAMOTO T, Hatakeyama S, Hosogoe S, Tanaka Y, et al
    Proton pump inhibitor as an independent factor of progression of abdominal aortic calcification in patients on maintenance hemodialysis.
    PLoS One. 2018;13:e0199160.
    PubMed     Text format     Abstract available


  70. MAUNOURY F, Clement A, Nwankwo C, Levy-Bachelot L, et al
    Cost-effectiveness analysis of elbasvir-grazoprevir regimen for treating hepatitis C virus genotype 1 infection in stage 4-5 chronic kidney disease patients in France.
    PLoS One. 2018;13:e0194329.
    PubMed     Text format     Abstract available


  71. CHEN CH, Lin CL, Jeng LB
    Association between chronic pancreatitis and urolithiasis: A population-based cohort study.
    PLoS One. 2018;13:e0194019.
    PubMed     Text format     Abstract available


  72. COLL M, Ferrer-Costa C, Pich S, Allegue C, et al
    Role of genetic and electrolyte abnormalities in prolonged QTc interval and sudden cardiac death in end-stage renal disease patients.
    PLoS One. 2018;13:e0200756.
    PubMed     Text format     Abstract available


  73. LIU WS, Lai YT, Chan HL, Li SY, et al
    Associations between perfluorinated chemicals and serum biochemical markers and performance status in uremic patients under hemodialysis.
    PLoS One. 2018;13:e0200271.
    PubMed     Text format     Abstract available


  74. ETINGER A, Kumar SR, Ackley W, Soiefer L, et al
    Correction: The effect of isohydric hemodialysis on the binding and removal of uremic retention solutes.
    PLoS One. 2018;13:e0200980.
    PubMed     Text format     Abstract available


  75. FIGUEIREDO PHS, Lima MMO, Costa HS, Martins JB, et al
    Effects of the inspiratory muscle training and aerobic training on respiratory and functional parameters, inflammatory biomarkers, redox status and quality of life in hemodialysis patients: A randomized clinical trial.
    PLoS One. 2018;13:e0200727.
    PubMed     Text format     Abstract available


  76. IGLESIAS-ESCUDERO M, Moro-Garcia MA, Marcos-Fernandez R, Garcia-Torre A, et al
    Levels of anti-CMV antibodies are modulated by the frequency and intensity of virus reactivations in kidney transplant patients.
    PLoS One. 2018;13:e0194789.
    PubMed     Text format     Abstract available


  77. GOLDENSTEIN PT, Graciolli FG, Antunes GL, Dominguez WV, et al
    A prospective study of the influence of the skeleton on calcium mass transfer during hemodialysis.
    PLoS One. 2018;13:e0198946.
    PubMed     Text format     Abstract available


  78. LOKHANDWALA S, McCague N, Chahin A, Escobar B, et al
    One-year mortality after recovery from critical illness: A retrospective cohort study.
    PLoS One. 2018;13:e0197226.
    PubMed     Text format     Abstract available


  79. LEE JY, Kim JS, Yang JW, Choi SO, et al
    Serum leptin level is associated with phase angle in CKD5 patients not undergoing dialysis.
    PLoS One. 2018;13:e0202055.
    PubMed     Text format     Abstract available


  80. RODELO-HAAD C, Rodriguez-Ortiz ME, Martin-Malo A, Pendon-Ruiz de Mier MV, et al
    Phosphate control in reducing FGF23 levels in hemodialysis patients.
    PLoS One. 2018;13:e0201537.
    PubMed     Text format     Abstract available


  81. MOTONISHI S, Tanaka K, Ozawa T
    Iron deficiency associates with deterioration in several symptoms independently from hemoglobin level among chronic hemodialysis patients.
    PLoS One. 2018;13:e0201662.
    PubMed     Text format     Abstract available


  82. OSHIMA M, Toyama T, Haneda M, Furuichi K, et al
    Estimated glomerular filtration rate decline and risk of end-stage renal disease in type 2 diabetes.
    PLoS One. 2018;13:e0201535.
    PubMed     Text format     Abstract available


  83. FERRER MD, Ketteler M, Tur F, Tur E, et al
    Characterization of SNF472 pharmacokinetics and efficacy in uremic and non-uremic rats models of cardiovascular calcification.
    PLoS One. 2018;13:e0197061.
    PubMed     Text format     Abstract available


  84. HAMOUDA E, El-Metwally S, Tarek M
    Ant Lion Optimization algorithm for kidney exchanges.
    PLoS One. 2018;13:e0196707.
    PubMed     Text format     Abstract available


  85. FUKUMA S, Kimachi M, Omae K, Kataoka Y, et al
    Dialysis physicians' referral behaviors for hemodialysis patients suspected of having cancer: A vignette-based questionnaire study.
    PLoS One. 2018;13:e0202322.
    PubMed     Text format     Abstract available


  86. NG JK, Kwan BC, Chow KM, Pang WF, et al
    Asymptomatic fluid overload predicts survival and cardiovascular event in incident Chinese peritoneal dialysis patients.
    PLoS One. 2018;13:e0202203.
    PubMed     Text format     Abstract available


  87. GOLESTANEH L, Bellin E, Neugarten J, Lo Y, et al
    Avoidable visits to the emergency department(ED) and their association with sex, age and race in a cohort of low socio-economic status patients on hemodialysis in the Bronx.
    PLoS One. 2018;13:e0202697.
    PubMed     Text format     Abstract available


  88. HSU CK, Lee CC, Chen YT, Ting MK, et al
    Multidisciplinary predialysis education reduces incidence of peritonitis and subsequent death in peritoneal dialysis patients: 5-year cohort study.
    PLoS One. 2018;13:e0202781.
    PubMed     Text format     Abstract available


  89. KAMEI Y, Kamei D, Tsuchiya K, Mineshima M, et al
    Association between 4-year all-cause mortality and carnitine profile in maintenance hemodialysis patients.
    PLoS One. 2018;13:e0201591.
    PubMed     Text format     Abstract available


  90. ORTEGA-PEREZ DE VILLAR L, Martinez-Olmos FJ, Junque-Jimenez A, Amer-Cuenca JJ, et al
    Test-retest reliability and minimal detectable change scores for the short physical performance battery, one-legged standing test and timed up and go test in patients undergoing hemodialysis.
    PLoS One. 2018;13:e0201035.
    PubMed     Text format     Abstract available


  91. SATO Y, Toida T, Nakagawa H, Iwakiri T, et al
    Diminishing dry weight is strongly associated with all-cause mortality among long-term maintenance prevalent dialysis patients.
    PLoS One. 2018;13:e0203060.
    PubMed     Text format     Abstract available


  92. SRIDHARAN S, Vilar E, Davenport A, Ashman N, et al
    Indexing dialysis dose for gender, body size and physical activity: Impact on survival.
    PLoS One. 2018;13:e0203075.
    PubMed     Text format     Abstract available


  93. WU HY, Huang JW, Tsai WC, Peng YS, et al
    Prognostic importance and determinants of uremic pruritus in patients receiving peritoneal dialysis: A prospective cohort study.
    PLoS One. 2018;13:e0203474.
    PubMed     Text format     Abstract available


  94. SANCHEZ-FERNANDEZ MDM, Reyes Del Paso GA, Gil-Cunquero JM, Fernandez-Serrano MJ, et al
    Executive function in end-stage renal disease: Acute effects of hemodialysis and associations with clinical factors.
    PLoS One. 2018;13:e0203424.
    PubMed     Text format     Abstract available


  95. LIU PJ, Ma F, Wang QY, He SL, et al
    The effects of oral nutritional supplements in patients with maintenance dialysis therapy: A systematic review and meta-analysis of randomized clinical trials.
    PLoS One. 2018;13:e0203706.
    PubMed     Text format     Abstract available


  96. LI L, Tang X, Kim S, Zhang Y, et al
    Effect of nocturnal hemodialysis on sleep parameters in patients with end-stage renal disease: a systematic review and meta-analysis.
    PLoS One. 2018;13:e0203710.
    PubMed     Text format     Abstract available


  97. NIU Q, Hong Y, Lee CH, Men C, et al
    Abdominal aortic calcification can predict all-cause mortality and CV events in dialysis patients: A systematic review and meta-analysis.
    PLoS One. 2018;13:e0204526.
    PubMed     Text format     Abstract available


  98. JANSZ TT, Bonenkamp AA, Boereboom FTJ, van Reekum FE, et al
    Health-related quality of life compared between kidney transplantation and nocturnal hemodialysis.
    PLoS One. 2018;13:e0204405.
    PubMed     Text format     Abstract available


  99. TSENG MF, Chou CL, Chung CH, Chien WC, et al
    Continuous veno-venous hemofiltration yields better renal outcomes than intermittent hemodialysis among traumatic intracranial hemorrhage patients with acute kidney injury: A nationwide population-based retrospective study in Taiwan.
    PLoS One. 2018;13:e0203088.
    PubMed     Text format     Abstract available


  100. FUJIWARA M, Ando I, Satoh K, Shishido Y, et al
    Biochemical evidence of cell starvation in diabetic hemodialysis patients.
    PLoS One. 2018;13:e0204406.
    PubMed     Text format     Abstract available


  101. WETMORE JB, Li S, Yan H, Xu H, et al
    Predialysis anemia management and outcomes following dialysis initiation: A retrospective cohort analysis.
    PLoS One. 2018;13:e0203767.
    PubMed     Text format     Abstract available


  102. MOTONISHI S, Tanaka K, Ozawa T
    Correction: Iron deficiency associates with deterioration in several symptoms independently from hemoglobin level among chronic hemodialysis patients.
    PLoS One. 2018;13:e0204789.
    PubMed     Text format     Abstract available


  103. YUE Q, Yin FT, Zhang Q, Yuan C, et al
    Carious status and supragingival plaque microbiota in hemodialysis patients.
    PLoS One. 2018;13:e0204674.
    PubMed     Text format     Abstract available


  104. KIM K, Son YK, Lee SM, Kim SE, et al
    Early technical complications and long-term survival of urgent peritoneal dialysis according to break-in periods.
    PLoS One. 2018;13:e0206426.
    PubMed     Text format     Abstract available


  105. RAMAN M, Middleton RJ, Kalra PA, Green D, et al
    Outcomes in dialysis versus conservative care for older patients: A prospective cohort analysis of stage 5 Chronic Kidney Disease.
    PLoS One. 2018;13:e0206469.
    PubMed     Text format     Abstract available


  106. HSU YH, Yen YC, Lin YC, Sung LC, et al
    Antiplatelet agents maintain arteriovenous fistula and graft function in patients receiving hemodialysis: A nationwide case-control study.
    PLoS One. 2018;13:e0206011.
    PubMed     Text format     Abstract available


  107. SUWABE T, Barrera-Flores FJ, Rodriguez-Gutierrez R, Ubara Y, et al
    Effect of online hemodiafiltration compared with hemodialysis on quality of life in patients with ESRD: A systematic review and meta-analysis of randomized trials.
    PLoS One. 2018;13:e0205037.
    PubMed     Text format     Abstract available


  108. DEBOWSKA M, Poleszczuk J, Dabrowski W, Wojcik-Zaluska A, et al
    Impact of hemodialysis on cardiovascular system assessed by pulse wave analysis.
    PLoS One. 2018;13:e0206446.
    PubMed     Text format     Abstract available


  109. AKIZAWA T, Shimazaki R, Fukagawa M
    Phase 2b study of evocalcet (KHK7580), a novel calcimimetic, in Japanese patients with secondary hyperparathyroidism undergoing hemodialysis: A randomized, double-blind, placebo-controlled, dose-finding study.
    PLoS One. 2018;13:e0204896.
    PubMed     Text format     Abstract available


  110. MARTINEZ GARCIA MA, Fernandez Rosales MS, Lopez Dominguez E, Hernandez Velazquez Y, et al
    Telemonitoring system for patients with chronic kidney disease undergoing peritoneal dialysis: Usability assessment based on a case study.
    PLoS One. 2018;13:e0206600.
    PubMed     Text format     Abstract available


  111. PAVO N, Yarragudi R, Puttinger H, Arfsten H, et al
    Parameters associated with therapeutic response using peritoneal dialysis for therapy refractory heart failure and congestive right ventricular dysfunction.
    PLoS One. 2018;13:e0206830.
    PubMed     Text format     Abstract available


  112. KIKUCHI H, Kanda E, Mori T, Sato H, et al
    Short-term prognosis of emergently hospitalized dialysis-independent chronic kidney disease patients: A nationwide retrospective cohort study in Japan.
    PLoS One. 2018;13:e0208258.
    PubMed     Text format     Abstract available


  113. REHMAN IU, Munib S, Ramadas A, Khan TM, et al
    Prevalence of chronic kidney disease-associated pruritus, and association with sleep quality among hemodialysis patients in Pakistan.
    PLoS One. 2018;13:e0207758.
    PubMed     Text format     Abstract available


  114. HUGHES J, Y Y Chiu D, Kalra PA, Green D, et al
    Prevalence and outcomes of proton pump inhibitor associated hypomagnesemia in chronic kidney disease.
    PLoS One. 2018;13:e0197400.
    PubMed     Text format     Abstract available


  115. ALLADAGBIN DJ, Fernandes PN, Tavares MB, Brito JT, et al
    The sickle cell trait and end stage renal disease in Salvador, Brazil.
    PLoS One. 2018;13:e0209036.
    PubMed     Text format     Abstract available


  116. PIETRIBIASI M, Waniewski J, Wojcik-Zaluska A, Zaluska W, et al
    Model of fluid and solute shifts during hemodialysis with active transport of sodium and potassium.
    PLoS One. 2018;13:e0209553.
    PubMed     Text format     Abstract available


  117. LEE KC, Hsu WH, Chou PH, Yiin JJ, et al
    Estimating the survival of elderly patients diagnosed with dementia in Taiwan: A longitudinal study.
    PLoS One. 2018;13:e0178997.
    PubMed     Text format     Abstract available


  118. PAI M, Adhikari NKJ, Ostermann M, Heels-Ansdell D, et al
    Low-molecular-weight heparin venous thromboprophylaxis in critically ill patients with renal dysfunction: A subgroup analysis of the PROTECT trial.
    PLoS One. 2018;13:e0198285.
    PubMed     Text format     Abstract available


  119. SOUWEINE JS, Kuster N, Chenine L, Rodriguez A, et al
    Physical inactivity and protein energy wasting play independent roles in muscle weakness in maintenance haemodialysis patients.
    PLoS One. 2018;13:e0200061.
    PubMed     Text format     Abstract available


  120. MCGREGOR G, Ennis S, Powell R, Hamborg T, et al
    Feasibility and effects of intra-dialytic low-frequency electrical muscle stimulation and cycle training: A pilot randomized controlled trial.
    PLoS One. 2018;13:e0200354.
    PubMed     Text format     Abstract available


  121. BORRELLI S, Chiodini P, De Nicola L, Minutolo R, et al
    Prognosis and determinants of serum PTH changes over time in 1-5 CKD stage patients followed in tertiary care.
    PLoS One. 2018;13:e0202417.
    PubMed     Text format     Abstract available


  122. GRAVESEN E, Nordholm A, Mace M, Morevati M, et al
    Effect of inhibition of CBP-coactivated beta-catenin-mediated Wnt signalling in uremic rats with vascular calcifications.
    PLoS One. 2018;13:e0201936.
    PubMed     Text format     Abstract available


  123. JANSZ TT, Neradova A, van Ballegooijen AJ, Verhaar MC, et al
    The role of kidney transplantation and phosphate binder use in vitamin K status.
    PLoS One. 2018;13:e0203157.
    PubMed     Text format     Abstract available


  124. HOLM NIELSEN S, Guldager Kring Rasmussen D, Brix S, Fenton A, et al
    A novel biomarker of laminin turnover is associated with disease progression and mortality in chronic kidney disease.
    PLoS One. 2018;13:e0204239.
    PubMed     Text format     Abstract available


  125. GONCALVES GMR, Silva END
    Cost of chronic kidney disease attributable to diabetes from the perspective of the Brazilian Unified Health System.
    PLoS One. 2018;13:e0203992.
    PubMed     Text format     Abstract available


  126. ANDREWS ES, Perrenoud L, Nowak KL, You Z, et al
    Examining the effects of uric acid-lowering on markers vascular of calcification and CKD-MBD; A post-hoc analysis of a randomized clinical trial.
    PLoS One. 2018;13:e0205831.
    PubMed     Text format     Abstract available


  127. KIM IY, Kim JH, Kim MJ, Lee DW, et al
    Plasma neutrophil gelatinase-associated lipocalin is independently associated with left ventricular hypertrophy and diastolic dysfunction in patients with chronic kidney disease.
    PLoS One. 2018;13:e0205848.
    PubMed     Text format     Abstract available


  128. YAN B, Su X, Xu B, Qiao X, et al
    Effect of diet protein restriction on progression of chronic kidney disease: A systematic review and meta-analysis.
    PLoS One. 2018;13:e0206134.
    PubMed     Text format     Abstract available


  129. KOSOKU A, Uchida J, Nishide S, Kabei K, et al
    ABO-incompatible kidney transplantation as a renal replacement therapy-A single low-volume center experience in Japan.
    PLoS One. 2018;13:e0208638.
    PubMed     Text format     Abstract available


    January 2017
  130. ABE M, Hamano T, Wada A, Nakai S, et al
    Effect of dialyzer membrane materials on survival in chronic hemodialysis patients: Results from the annual survey of the Japanese Nationwide Dialysis Registry.
    PLoS One. 2017;12:e0184424.
    PubMed     Text format     Abstract available


  131. NAKAYAMA M, Itami N, Suzuki H, Hamada H, et al
    Possible clinical effects of molecular hydrogen (H2) delivery during hemodialysis in chronic dialysis patients: Interim analysis in a 12 month observation.
    PLoS One. 2017;12:e0184535.
    PubMed     Text format     Abstract available


  132. KAO CC, Yang JY, Chen L, Chao CT, et al
    Factors associated with poor outcomes of continuous renal replacement therapy.
    PLoS One. 2017;12:e0177759.
    PubMed     Text format     Abstract available


  133. YACOUB R, Nugent M, Cai W, Nadkarni GN, et al
    Advanced glycation end products dietary restriction effects on bacterial gut microbiota in peritoneal dialysis patients; a randomized open label controlled trial.
    PLoS One. 2017;12:e0184789.
    PubMed     Text format     Abstract available


  134. YAGUCHI A, Tatemichi S, Takeda H, Kobayashi M, et al
    PA21, a novel phosphate binder, improves renal osteodystrophy in rats with chronic renal failure.
    PLoS One. 2017;12:e0180430.
    PubMed     Text format     Abstract available


  135. LIN WC, Lin HH, Hung CY, Shih SC, et al
    Clinical endoscopic management and outcome of post-endoscopic sphincterotomy bleeding.
    PLoS One. 2017;12:e0177449.
    PubMed     Text format     Abstract available


  136. SEPANLOU SG, Barahimi H, Najafi I, Kamangar F, et al
    Prevalence and determinants of chronic kidney disease in northeast of Iran: Results of the Golestan cohort study.
    PLoS One. 2017;12:e0176540.
    PubMed     Text format     Abstract available


  137. SHIN DH, Lee YK, Oh J, Yoon JW, et al
    Vascular calcification and cardiac function according to residual renal function in patients on hemodialysis with urination.
    PLoS One. 2017;12:e0185296.
    PubMed     Text format     Abstract available


  138. NAKAZATO Y, Kurane R, Hirose S, Watanabe A, et al
    Aging and death-associated changes in serum albumin variability over the course of chronic hemodialysis treatment.
    PLoS One. 2017;12:e0185216.
    PubMed     Text format     Abstract available


  139. LITTERA R, Piredda G, Argiolas D, Lai S, et al
    KIR and their HLA Class I ligands: Two more pieces towards completing the puzzle of chronic rejection and graft loss in kidney transplantation.
    PLoS One. 2017;12:e0180831.
    PubMed     Text format     Abstract available


  140. WANG HH, Hung SY, Chang MY, Lee YC, et al
    Bacterial colonization patterns in daily chlorhexidine care at the exit site in peritoneal dialysis patients-A prospective, randomized controlled trial.
    PLoS One. 2017;12:e0184859.
    PubMed     Text format     Abstract available


  141. LEE JE, Lim JH, Jang HM, Kim YS, et al
    Low serum phosphate as an independent predictor of increased infection-related mortality in dialysis patients: A prospective multicenter cohort study.
    PLoS One. 2017;12:e0185853.
    PubMed     Text format     Abstract available


  142. AOUN M, Koubar SH, Antoun L, Tamim H, et al
    Reduction of intracerebral hemorrhage in hemodialysis patients after reducing aspirin use: A quality-assurance observational study.
    PLoS One. 2017;12:e0185847.
    PubMed     Text format     Abstract available


  143. BURNHAM JP, Micek ST, Kollef MH
    Augmented renal clearance is not a risk factor for mortality in Enterobacteriaceae bloodstream infections treated with appropriate empiric antimicrobials.
    PLoS One. 2017;12:e0180247.
    PubMed     Text format     Abstract available


  144. BAILIE C, Kilner J, Maxwell AP, McKnight AJ, et al
    Development of next generation sequencing panel for UMOD and association with kidney disease.
    PLoS One. 2017;12:e0178321.
    PubMed     Text format     Abstract available


  145. RADAKOVIC D, Reboredo J, Helm M, Weigel T, et al
    A multilayered electrospun graft as vascular access for hemodialysis.
    PLoS One. 2017;12:e0185916.
    PubMed     Text format     Abstract available


  146. ELOOT S, Van Biesen W, Roels S, Delrue W, et al
    Spontaneous variability of pre-dialysis concentrations of uremic toxins over time in stable hemodialysis patients.
    PLoS One. 2017;12:e0186010.
    PubMed     Text format     Abstract available


  147. ANGERMANN S, Baumann M, Steubl D, Lorenz G, et al
    Cognitive impairment in hemodialysis patients: Implementation of cut-off values for the Montreal Cognitive Assessment (MoCA)-test for feasible screening.
    PLoS One. 2017;12:e0184589.
    PubMed     Text format     Abstract available


  148. ROGAN A, McCarthy K, McGregor G, Hamborg T, et al
    Quality of life measures predict cardiovascular health and physical performance in chronic renal failure patients.
    PLoS One. 2017;12:e0183926.
    PubMed     Text format     Abstract available


  149. CHO A, Lee YK, Oh J, Yoon JW, et al
    The relationship between intradialytic hypotension and vascular calcification in hemodialysis patients.
    PLoS One. 2017;12:e0185846.
    PubMed     Text format     Abstract available


  150. KSHIRSAGAR AV, Manickam RN, Mu Y, Flythe JE, et al
    Area-level poverty, race/ethnicity & dialysis star ratings.
    PLoS One. 2017;12:e0186651.
    PubMed     Text format     Abstract available


  151. KUBO Y, Imaizumi T, Ando M, Nakatochi M, et al
    Association between kidney function and genetic polymorphisms in atherosclerotic and chronic kidney diseases: A cross-sectional study in Japanese male workers.
    PLoS One. 2017;12:e0185476.
    PubMed     Text format     Abstract available


  152. TSAI YC, Chen HM, Hsiao SM, Chen CS, et al
    Association of physical activity with cardiovascular and renal outcomes and quality of life in chronic kidney disease.
    PLoS One. 2017;12:e0183642.
    PubMed     Text format     Abstract available


  153. MITSIDES N, Cornelis T, Broers NJH, Diederen NMP, et al
    Extracellular overhydration linked with endothelial dysfunction in the context of inflammation in haemodialysis dependent chronic kidney disease.
    PLoS One. 2017;12:e0183281.
    PubMed     Text format     Abstract available


  154. DOWER K, Zhao S, Schlerman FJ, Savary L, et al
    High resolution molecular and histological analysis of renal disease progression in ZSF1 fa/faCP rats, a model of type 2 diabetic nephropathy.
    PLoS One. 2017;12:e0181861.
    PubMed     Text format     Abstract available


  155. BORRAS SANS M, Perez-Fontan M, Martinez-Alonso M, Bajo A, et al
    The modality of dialysis does not influence atheromatous vascular disease progression or cardiovascular outcomes in dialysis patients without previous cardiovascular disease.
    PLoS One. 2017;12:e0186921.
    PubMed     Text format     Abstract available


  156. TORINO C, Pizzini P, Cutrupi S, Tripepi R, et al
    Vitamin D and methylarginines in chronic kidney disease (CKD).
    PLoS One. 2017;12:e0185449.
    PubMed     Text format     Abstract available


  157. CHIU HY, Huang WY, Ho CH, Wang JJ, et al
    Increased risk of chronic kidney disease in patients with rosacea: A nationwide population-based matched cohort study.
    PLoS One. 2017;12:e0180446.
    PubMed     Text format     Abstract available


  158. LANGOTE A, Hiremath S, Ruzicka M, McCormick BB, et al
    Spironolactone is effective in treating hypokalemia among peritoneal dialysis patients.
    PLoS One. 2017;12:e0187269.
    PubMed     Text format     Abstract available


  159. PIOVESAN F, Tres GS, Moreira LB, Andrades ME, et al
    Effect of diacerein on renal function and inflammatory cytokines in participants with type 2 diabetes mellitus and chronic kidney disease: A randomized controlled trial.
    PLoS One. 2017;12:e0186554.
    PubMed     Text format     Abstract available


  160. SIRICH TL, Aronov PA, Fullman J, Nguyen K, et al
    Untargeted mass spectrometry discloses plasma solute levels poorly controlled by hemodialysis.
    PLoS One. 2017;12:e0188315.
    PubMed     Text format     Abstract available


  161. SU X, Xu B, Yan B, Qiao X, et al
    Effects of uric acid-lowering therapy in patients with chronic kidney disease: A meta-analysis.
    PLoS One. 2017;12:e0187550.
    PubMed     Text format     Abstract available


  162. ADJEI DN, Stronks K, Adu D, Snijder MB, et al
    Relationship between educational and occupational levels, and Chronic Kidney Disease in a multi-ethnic sample- The HELIUS study.
    PLoS One. 2017;12:e0186460.
    PubMed     Text format     Abstract available


  163. LIN YC, Lin JW, Wu MS, Chen KC, et al
    Effects of calcium channel blockers comparing to angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in patients with hypertension and chronic kidney disease stage 3 to 5 and dialysis: A systematic review and meta-analysis.
    PLoS One. 2017;12:e0188975.
    PubMed     Text format     Abstract available


  164. ROBERTS PR, Zachariah D, Morgan JM, Yue AM, et al
    Monitoring of arrhythmia and sudden death in a hemodialysis population: The CRASH-ILR Study.
    PLoS One. 2017;12:e0188713.
    PubMed     Text format     Abstract available


  165. WANG TL, Fang YW, Leu JG, Tsai MH, et al
    Association between serum aluminum levels and cardiothoracic ratio in patients on chronic hemodialysis.
    PLoS One. 2017;12:e0190008.
    PubMed     Text format     Abstract available


  166. HEAF J, Petersons A, Vernere B, Heiro M, et al
    Why do physicians prescribe dialysis? A prospective questionnaire study.
    PLoS One. 2017;12:e0188309.
    PubMed     Text format     Abstract available


  167. EICH G, Bartosova M, Tischer C, Wlodkowski TT, et al
    Bicarbonate buffered peritoneal dialysis fluid upregulates angiopoietin-1 and promotes vessel maturation.
    PLoS One. 2017;12:e0189903.
    PubMed     Text format     Abstract available


  168. CHANCHAROENTHANA W, Leelahavanichkul A, Taratummarat S, Wongphom J, et al
    Cilostazol attenuates intimal hyperplasia in a mouse model of chronic kidney disease.
    PLoS One. 2017;12:e0187872.
    PubMed     Text format     Abstract available


  169. CUZIN L, Pugliese P, Allavena C, Rey D, et al
    Antiretroviral therapy as a risk factor for chronic kidney disease: Results from traditional regression modeling and causal approach in a large observational study.
    PLoS One. 2017;12:e0187517.
    PubMed     Text format     Abstract available


  170. CHERTOW GM, Block GA, Neylan JF, Pergola PE, et al
    Safety and efficacy of ferric citrate in patients with nondialysis-dependent chronic kidney disease.
    PLoS One. 2017;12:e0188712.
    PubMed     Text format     Abstract available


  171. DAI L, Mukai H, Lindholm B, Heimburger O, et al
    Clinical global assessment of nutritional status as predictor of mortality in chronic kidney disease patients.
    PLoS One. 2017;12:e0186659.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Chronic Renal Failure is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: